Plaintiffs File Motion For Economic Loss Settlement With Party In Valsartan MDL
CAMDEN, N.J. — Plaintiffs in the valsartan, losartan and irbesartan hypertension drugs multidistrict litigation pending in a New Jersey federal court moved for a preliminary approval of a $2 million settlement...To view the full article, register now.
Already a subscriber? Click here to view full article